Com.Pl.i.t DX® is a portfolio of molecular cancer testing panels designed to characterize clinically relevant genomic alterations across multiple solid tumors. The panels support comprehensive molecular profiling and biomarker detection, providing genomic information that can assist clinicians in precision oncology and treatment decision-making.